9926.HK 财务： Akeso, Inc. AI 分析

Q: 技术分析指标如何适用于 9926.HK？

根据技术分析，Akeso, Inc. 的综合信号为 Buy。Akeso, Inc. 有 3 个买入信号，2 个中性信号和 2 个卖出信号。

Q: 9926.HK 的斐波那契回调水平是多少？

Akeso, Inc. 的斐波那契回调水平是 低于100%的水平。

Q: Akeso, Inc. 的 RSI 是多少？

Akeso, Inc. 的 RSI 目前为 49.07，表明处于 中立 状态

Q: Akeso, Inc. 接下来 12 个月的价格是多少？

Akeso, Inc. 9926.HK 接下来 12 个月的价格预计为 $173.04。

Q: Akeso, Inc. 预计会涨到多高？

据华尔街分析师称，Akeso, Inc. 预计将达到 $237.3 的高预测值。

主页

股票

9926.HK

预测

AKESO (9926.HK)

Akeso, Inc.

HK$121

-1.06%

$-1.29

休市： Jan 19, 12:00:00 HKT

关键数据

前收盘价

$121

开盘价

$122.3

当日区间

$118.6 - $122.5

52周范围

$55.65 - $179

交易量

5.1M

平均成交量

6.6M

每股收益（TTM）

-1.07

股息收益率

市值

$111.4B

什么是 AKESO？

Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for 9926.HK in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $173.04. The lowest target is $101 and the highest is $237.3. Empower your investment choices with our cutting-edge, data-driven analysis!

9926.HK 股价预测摘要

9926.HK的顶级分析师评级

基于 29 位分析师对 9926.HK 的股票评级，更新于 Jan 01, 2026

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for 9926.HK. Our analysts highlight strong fundamentals and favorable market sentiment, positioning 9926.HK for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: 9926.HK is a Strong Buy candidate.

9926.HK stock price ended at $121 on 星期五, after dropping 0.74%

On the latest trading day Jan 16, 2026, the stock price of 9926.HK fell by 0.74%, dropping from $122.30 to $121.00. During the session, the stock saw a volatility of 3.29%, with prices oscillating between a daily low of $118.60 and a high of $122.50. On the latest trading day, the trading volume for 9926.HK rose by 1.9M shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 5.1M shares were traded, with a market value of approximately $111.4B.

9926.HK 技术面信号

技术面信号摘要

购买信号 3

中性信号 2

卖出信号 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

9926.HK目前显示3个买入信号和2个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-1.94%。总体而言，技术指标显示中期前景为Buy。

9926.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 9926.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 9926.HK？



9926.HK 的斐波那契回调水平是多少？



Akeso, Inc. 的 RSI 是多少？



Akeso, Inc. 接下来 12 个月的价格是多少？



Akeso, Inc. 预计会涨到多高？



Akeso, Inc.（9926.HK）价格

9926.HK 股价走势图